Ximing J Yang

  • 9472 Citations
1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

General Surgical Pathology and Urological Surgical Pathology Diagnosis of genital urinary cancers including prostate, bladder, kidney, testis and other GU organs Immunohistochemistry

Pathogenesis of prostate cancer, kidney cancer and bladder cancer Identification of new molecular markers of GU cancers Solid tumor banking for biological studies

Certifications and Licenses

Anatomic Pathology & Clinical Pathology

Training Experience

1997Residency, University of Chicago Hospitals
1998Fellowship, Johns Hopkins Hospital

Education/Academic qualification

PhD, University of California, San Diego

… → 1989

MD, Beijing Medical University

… → 1982

Research interests

  • Bladder Cancer
  • Kidney Cancer / Urinary Tract Cancer
  • Pathology
  • Prostate Cancer

Fingerprint Dive into the research topics where Ximing J Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • Research Output

    Application and pitfalls of immunohistochemistry in diagnosis of challenging genitourinary cases

    Ross, J., Li, G. & Yang, X. J., Jan 1 2020, In : Archives of Pathology and Laboratory Medicine. 144, 3, p. 290-304 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • Erratum: Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion (Clinical Cancer Research (2011) 17 (1297–1305) DOI: 10.1158/1078-0432.CCR-10-0993)

    Wei, J. J., Wu, X., Peng, Y., Shi, G., Olca, B., Yang, X., Daniels, G., Osman, I., Ouyang, J., Hernando, E., Pellicer, A., Rhim, J. S., Melamed, J. & Lee, P., Mar 1 2020, In : Clinical Cancer Research. 26, 5, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys

    Lin, X., Goyal, R. & Yang, X. J., Mar 2020, In : Human pathology. 97, p. 1-7 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Activation of MAPK Signaling by CXCR7 leads to enzalutamide resistance in prostate cancer

    Li, S., Fong, K. W., Gritsina, G., Zhang, A., Zhao, J. C., Kim, J., Sharp, A., Yuan, W., Aversa, C., Yang, X. J., Nelson, P. S., Feng, F. Y., Chinnaiyan, A. M., De Bono, J. S., Morrissey, C., Rettig, M. B. & Yu, J., Jan 1 2019, In : Cancer Research. 79, 10, p. 2580-2592 13 p.

    Research output: Contribution to journalArticle

  • 8 Scopus citations

    Genistein treatment duration effects biomarkers of cell motility in human prostate

    Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 2019, In : PloS one. 14, 3, e0214078.

    Research output: Contribution to journalArticle

    Open Access
  • 6 Scopus citations